18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country's first new prescription diet drug in over a decade.
STOCK SURGE: Shares nearly doubled in after-hours trading, as lorcaserin could become the small company's first approved product.
NEXT STEPS: Maker Arena Pharmaceuticals says it will work with the FDA as it finishes its review, with a June 27 target for a final decision. The agency had rejected lorcaserin in 2010 over possible heart risks, but Arena tried again with additional data.
Judging By The Choices For Time’s Person Of The Year, 2014 Was An Awful Year For Humans | Derek Hunter